Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial
Julio Ancochea, Francisco García-Río, Emma Vázquez-Espinosa, Ascensión Hernando-Sanz, Luis López-Yepes, Raúl Galera-Martínez, Germán Peces-Barba, Maria Teresa Pérez-Warnisher, Gonzalo Segrelles-Calvo, Celia Zamarro, Pablo González-Ponce, M. Inmaculata Ramos, Jose Ignacio Conforto, Syed Jafri, Joan B. Soriano
Source: Eur Respir J, 51 (5) 1800354; 10.1183/13993003.00354-2018
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Julio Ancochea, Francisco García-Río, Emma Vázquez-Espinosa, Ascensión Hernando-Sanz, Luis López-Yepes, Raúl Galera-Martínez, Germán Peces-Barba, Maria Teresa Pérez-Warnisher, Gonzalo Segrelles-Calvo, Celia Zamarro, Pablo González-Ponce, M. Inmaculata Ramos, Jose Ignacio Conforto, Syed Jafri, Joan B. Soriano. Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial. Eur Respir J, 51 (5) 1800354; 10.1183/13993003.00354-2018
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: